Colesevelam curbs glucose concentration in study

01/31/2013 | PhysiciansBriefing.com

Colesevelam therapy was associated with lower fasting and postprandial glucose concentrations in type 2 diabetes patients on metformin monotherapy, a study in Diabetes found. Researchers also discovered colesevelam did not affect insulin concentration, secretion or action in patients.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN